Amnio Technology, LLC receives its first US patent for placental tissue allograft
Accelular amnion derived therapeutic compositions. Amnion derived materials continue to be evaluated for use in a wide array of clinical conditions. Amnio Technology is dedicated to advancing the science of regenerative medicine by developing and introducing new placental tissue allografts and technologies
Recent Comments